Cell Growth & Differentiation, Vol 5, Issue 12 1333-1338, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells

J Liu, RI Grove and RE Vestal
Molecular Pharmacology Research Laboratory, Department of Veterans Affairs Medical Center, Boise, Idaho 83702.

Oncostatin M (OM), a cytokine produced by macrophages and activated T cells, has been shown to be a potent inducer of liver low density lipoprotein receptor (LDLR) activity by increasing LDL uptake and cell surface LDLR number in HepG2 cells. To investigate whether OM regulates the transcription of the LDLR gene and if the effect is independent of the sterol pathway, we examined the effects of OM on the promoter activity of the LDLR gene and the expression of LDLR mRNA. HepG2 cells were transfected with hybrid genes containing three different lengths of DNA fragments from the 5' flanking region of the LDLR gene that were fused to the coding region of the chloramphenicol acetyltransferase (CAT) gene. OM induced an approximately 3-fold increase in CAT activities in pLDLR-CAT vector-transfected cells that were incubated in lipoprotein-depleted medium and a 6-fold increase in CAT activities when the transfected cells were treated with sterols. OM stimulated similar increases in CAT activities in HepG2 cells transfected with pLDLR-CAT 234, pLDLR-CAT 1563, and pLDLR-CAT 6500, suggesting that the essential cis-acting element that mediates the OM effect is located within the 177 base pairs upstream of the transcription start site of the LDLR gene. Examination of the regulation of the endogenous LDLR mRNA expression by OM gave results similar to those in transfected cells. OM increased the levels of mRNA of LDLR, regardless of the presence or absence of lipoprotein and sterols. These data suggest that the up-regulation of the LDLR by OM is at the transcriptional level through a nonsterol mediated mechanism.

This article has been cited by other articles:

				W. Kong, P. Abidi, F. B. Kraemer, J.-D. Jiang, and J. Liu In vivo activities of cytokine oncostatin M in the regulation of plasma lipid levels J. Lipid Res., June 1, 2005; 46(6): 1163 - 1171. [Abstract] [Full Text] [PDF]

				J. Liu, F. Zhang, C. Li, M. Lin, and M. R. Briggs Synergistic Activation of Human LDL Receptor Expression by SCAP Ligand and Cytokine Oncostatin M Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 90 - 96. [Abstract] [Full Text] [PDF]

				F. Zhang, T. E. Ahlborn, C. Li, F. B. Kraemer, and J. Liu Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol-independent regulatory element of human LDL receptor promoter J. Lipid Res., September 1, 2002; 43(9): 1477 - 1485. [Abstract] [Full Text] [PDF]

				J. Liu, T. E. Ahlborn, M. R. Briggs, and F. B. Kraemer Identification of a Novel Sterol-independent Regulatory Element in the Human Low Density Lipoprotein Receptor Promoter J. Biol. Chem., February 18, 2000; 275(7): 5214 - 5221. [Abstract] [Full Text] [PDF]

				C. Li, F. B. Kraemer, T. E. Ahlborn, and J. Liu Induction of Low Density Lipoprotein Receptor (LDLR) Transcription by Oncostatin M Is Mediated by the Extracellular Signal-regulated Kinase Signaling Pathway and the Repeat 3 Element of the LDLR Promoter J. Biol. Chem., March 5, 1999; 274(10): 6747 - 6753. [Abstract] [Full Text] [PDF]

				J. Liu, Y. L. Zhang, M. J. Spence, R. E. Vestal, P. M. Wallace, and D. S. Grass Liver LDL Receptor mRNA Expression Is Decreased in Human ApoB/CETP Double Transgenic Mice and Is Regulated by Diet as Well as the Cytokine Oncostatin M Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2948 - 2954. [Abstract] [Full Text]

				C. S. Moran, J. H. Campbell, and G. R. Campbell Human Leukemia Inhibitory Factor Upregulates LDL Receptors on Liver Cells and Decreases Serum Cholesterol in the Cholesterol-Fed Rabbit Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1267 - 1273. [Abstract] [Full Text]